RPL9P30

Across TCGA pan-cancer cohorts, RPL9P30 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL9P30’s most consistent transcriptional readouts.

The strongest signal is observed in rectum adenocarcinoma (READ), where RPL9P30 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL9P30 is over-expressed in tumor, although a few such as READ show the opposite, repressed pattern.

READ and BRCA are the cancer types where RPL9P30 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL9P30 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
READ	Male	All	−0.170	.008	5	view →
BRCA	All	All	+0.145	.030	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL9P30–READ

Open the READ breakdown →